Table 1.
Characteristics of the study population by EAT volume tertile.
| Tertile 1 (SD) (n = 46) | Min–Max | Tertile 2 (SD) (n = 46) | Min–Max | Tertile 3 (SD) (n = 46) | Min–Max | p | |
|---|---|---|---|---|---|---|---|
| Age (years) | 61.4 (12.2) | 29–77 | 65.4 (8.6) | 44-82 | 67.2 (10.0) | 47-86 | 0.025 |
| Sex (M) n (%) | 34 (73.9%) | 57 (80.4%) | 38 (82.6%) | 0.567 | |||
| Height (m) | 1.7 (0.1) | 1.40–1.96 | 1.7 (0.1) | 1.60–1.94 | 1.7 (0.1) | 1.55–1.90 | 0.810 |
| Weight (Kg) | 81.9 (12.9) | 46–112 | 89.5 (18.7) | 63–157 | 89.7 (13.5) | 68–127 | 0.023 |
| BMI (Kg/m2) | 27.7 (3.1) | 20.4–34.3 | 29.9 (5.3) | 22.5–51.9 | 30.1 (4.4) | 24.2–41.5 | 0.014 |
| Epicardial fat density (HU) | −72.8 (8.1) | −93.0–53.2 | −76.2 (6.6) | −93.9–57.3 | −83.6 (9.1) | −101.6–55.9 | <0.001 |
| APACHE II | 17.1 (7.8) | 4–33 | 19.5 (8.3) | 6–36 | 20.6 (9.6) | 4–53 | 0.138 |
| CRP (mg/dL) | 130.8 (94.1) | 4–410 | 122.6 (77.7) | 21–348 | 112.8 (71.7) | 9–259 | 0.572 |
| D-Dimer (ng/mL) | 1927.4 (2584.4) | 250–10,000 | 2284.3 (2589.2) | 150–10,000 | 2538.7 (3147.5) | 120-10,000 | 0.573 |
| LDH (U/L) | 368.7 (130.1) | 55.0–729.0 | 407.9 (260.4) | 11.0–1544.0 | 184.3 (146.8) | 60.0–776.0 | 0.604 |
| IL-6 (pg/mL) | 23.9 (36.4) | 6.7–168.1 | 66.2 (81.2) | 7.8–367.0 | 142.9 (163.3) | 7.8–500.0 | <0.001 |
| Hypertension | 27 (58.7%) | 26 (56.5%) | 26 (56.5%) | 0.971 | |||
| Hearth failure | 1 (2.2%) | 2 (4.3%) | 1 (2.2%) | 0.773 | |||
| Ischemic cardiopathy | 3 (6.5%) | 3 (6.5%) | 3 (6.5%) | 1.000 | |||
| Neurological disorder | 1 (2.2%) | 4 (8.7%) | 5 (10.9%) | 0.246 | |||
| Type 2 Diabetes | 8 (17.4%) | 8 (17.4%) | 12 (26.1%) | 0.488 | |||
| Thyroid | 4 (8.7%) | 10 (21.7%) | 3 (6.5%) | 1.000 | |||
| Dyslipidemia | 6 (13.0%) | 10 (21.7%) | 8 (17.4%) | 0.546 | |||
| Immunodepression | 3 (6.5%) | 3 (6.5%) | 5 (10.9%) | 0.674 | |||
| Smoke habit | 9 (19.6%) | 3 (6.5%) | 8 (17.4%) | 0.163 | |||
| Chronic renal failure | 2 (4.3%) | 5 (10.9%) | 6 (13.0%) | 0.332 | |||
| Cancer | 3 (6.5%) | 6 (13.0%) | 6 (13.0%) | 0.510 | |||
| Embolia | 3 (6.5%) | 10 (21.7%) | 13 (28.3%) | 0.024 | |||
| 28 Daysa Mortality | 6 (13.0%) | 9 (19.6%) | 13 (28.3%) | 0.191 |
EAT Epicardial Adipose Tissue, SD standard deviation, BMI body mass index, HU Hounsfield units, CRP C reactive protein, CPK creatin phosphokinase, LDH lactate dehydrogenase, aSince Intensive Care Unit admission.